PatientsVille.com Logo

Neuropathy and Oxycontin

PatientsVille

Neuropathy Symptoms and Causes

If you have diabetes, your blood glucose, or blood sugar, levels are too high. Over time, this can damage the covering on your nerves or the blood vessels that bring oxygen to your nerves. Damaged nerves may stop sending messages, or may send messages slowly or at the wrong times.

This damage is called diabetic Neuropathy. Over half of people with diabetes get it. Symptoms may include

  • Numbness in your hands, legs, or feet
  • Shooting pains, burning, or tingling
  • Nausea, vomiting, constipation, or diarrhea
  • Problems with sexual function
  • Urinary problems
  • Dizziness when you change positions quickly

Your doctor will diagnose diabetic Neuropathy with a physical exam and nerve tests. Controlling your blood sugar can help prevent nerve problems, or keep them from getting worse. Treatment may include pain relief and other medicines.

NIH: National Institute of Diabetes and Digestive and Kidney Diseases

Check out the latest treatments for neuropathy

neuropathy treatment research studies

Oxycontin clinical trials, surveys and public health registries


Find Drug Side Effect reports



Oxycontin Side Effects

Anxiety (606)
Pain (554)
Depression (486)
Nausea (432)
Overdose (409)
Constipation (367)
Back Pain (360)
Death (321)
Arthralgia (314)
Vomiting (309)
Substance Abuse (306)
Headache (292)
Asthenia (278)
Diarrhoea (272)
Inadequate Analgesia (270)
Abdominal Pain Upper (251)
Abdominal Pain (238)
Polysubstance Abuse (233)
Coma (231)
Somnolence (227)
Confusional State (208)
Malaise (205)
Agitation (189)
Hyperhidrosis (180)
Accidental Overdose (180)
Chest Pain (174)
Product Formulation Issue (174)
Insomnia (170)
Loss Of Consciousness (167)
Amnesia (165)
Fall (159)
Dyspnoea (157)
Suicidal Ideation (152)
Anorexia (140)
Chills (140)
Dizziness (138)
Aggression (136)
Feeling Abnormal (125)
Euphoric Mood (124)
Decreased Appetite (123)
Condition Aggravated (123)
Fatigue (121)
Anger (121)
Completed Suicide (120)
Abdominal Discomfort (113)
Road Traffic Accident (113)
Blood Pressure Increased (112)
Lethargy (109)
Pruritus (102)
Myocardial Infarction (97)

➢ More


Common Meds

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)
Zoloft(6792)
Zyrtec(1669)

Recent Reviews

have been taking dulotine 90mg and oxycontin 40mg pregablin 75mg would this damage my kidneys

GRAAG ZOU IK MEER WILLEN WETEN OVER OXYCONTIN BIJ ERNSTIGE COPD. HUISARTS SCHRIJFT OXYCONTIN VOOR OM DE ERGSTE BENAUWDHEID TE VERMINDEREN. IK GEBRUIK 2DD 20 MG. RETARD. LONGARTS IS TEGEN DIT GEBRUIK EN WIL ME LATEN STOPPEN. SINDS 2 JAAR

Had left half of an 40mg Oxycontin pill on my night stand! Came back about an hour later and was unable to locate pill! Time was approximately 5:00 PM! 4 to 4 1/2 hours later, younger stepsister, age 8, strangely says she took pill by accident! What

Hi, I'm not exsperiencing this first hand, but I am second hand. My bestfriend is. Let me tell you, I feel like I am. She has 7 days under he belt offically. I am so proud of her, considering how she was day 5 and 7, I don't think many people would s

How does it affect ur families

I also have neuropathy which started in my legs but now it's all over my body. I takegabytan but can only take up to 300mg and it's no longer working. I also take vicadin but had to stop because it was making my blood pressure very low. Any

I have lost (broken off) seven lower teeth in last 60 days. Dentist say because OXYICONTIN causes severe dry mouth which creates optimal conditions for getting cavities and super fast (No cavities needing feeling at cleaning and NINE six months later

I have recently started having terrible knee pain on both knees. What can I do to stop the pain?

Severe back pain that goes throught to my stomach. i also feel very lehargic and i have wet myself a few times

<span style='text-decoration: underline;'>My girlfriend experieces SEVERE neuropathy NOT slight!

Also, (my mom is 77 post). She is taking the neuropathy drug Neurontin. She is on so many meds, not sure which one is helping the pain.

Any report of anterior ischemic optic neuropathy with dasatinib?

Get off that stuff and get off of it fast!I took macrobid and macrodantin for 2 years for UTI's and now several years later I have peripheral neuropathy so bad in my feet I am in a wheelchair. Also since it is progressive in my hands now. Stay away

Have been on Spiriva for 7 years. Have always dry eyes, mild urinary issues etc. Three years ago developed neuropathy, Dr. said it could not be from Spiriiva but drug at least AFFECTS it. Cut down from 2 puffs on one dose to 1 puff and pain diminish

Hi - all sufferers: I was given Lyrica to replace Morphine Sulfate (timed release) for Diabetic Neuropathy - foot pain, now present for 2 years. I am at 225mg Lyrica - and I am losing my mind ! I agree with everything Ted said, but the physical la

I also have neuropathy which started in my legs but now it's all over my body. I takegabytan but can only take up to 300mg and it's no longer working. I also take vicadin but had to stop because it was making my blood pressure very low. Any

I am 29 F and have been on Lyrica for 2 years. I have DDD 3 disc herniations and neuropathy in my leg,nerve root in back and in my neck. Had one surgery in 09 but have permanent nerve damage in sciatic nerve. Ok So Lyrica really helped my leg pain wh

I am 62 years oldfemale and I have peripheral neuropathy. I took Mucinex-D last night and I could not go to sleep. After sleeping for anhour I wakeupand was verynervous, dizzy andhypertensiv

I am a methycobal taker ( 1 tablet/day - 500mg) for almost 6 years due to neuropathy on my feet. So far, it has helped me a lot. Thanks and more power. :&gt;)

Neuropathy Clinical Trials and Studies

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.
Rank Status Study
1 Unknown  Can Ultrasound Predict Nerve Injury Following Posterior Tibial Nerve Block in Patients With Peripheral Neuropathy?
Condition: Diabetic Neuropathy
Intervention: Procedure: Nerve conduction study and Ultrasound of the PTN
Outcome Measures: Interval worsening of the severity of Neuropathy;   New functional Neuropathy defined as any new sensory or motor deficit compared to preoperatively.
2 Unknown  Use of Topical Lidocaine to Reduce Pain in Patients With Diabetic Neuropathy
Condition: Diabetic Peripheral Neuropathy
Intervention: Other: Skin biopsy
Outcome Measure: To determine if the lidocaine patch provides therapeutic benefit to patients with painful diabetic Neuropathy.
3 Not yet recruiting Safety and Tolerability of Lacosamide in Patients With Gain-of-function Nav1.7 Mutations Related Small Fiber Neuropathy
Condition: Small Fiber Neuropathy
Interventions: Drug: Lacosamide;   Drug: Placebo
Outcome Measures: Pain Intensity Numerical Rating Scale;   Daily Sleep Interference Scale;   • Adverse Events, Laboratory Safety Tests (Hematology, Clinical Chemistry, Urinalysis), Blood Pressure, Pulse Rate, ECG.;   Small Fiber Neuropathy Symptoms Inventory Questionnaire (SFN-SIQ).;   Patient Global Impression of Change (PGIC).;   Neuropathic Pain Scale (NPS).
4 Unknown  A Clinical Outcomes Study to Measure Reduction in Pain and Numbness During Administration of an Amino Acid Formulation in Subjects Diagnosed With Peripheral Neuropathy
Conditions: Diabetic Neuropathy;   Chemotherapy Induced Neuropathy;   HIV Neuropathy;   Trauma Induced Neuropathy
Intervention: Drug: Neuron012703 (Medical Food)
Outcome Measures: VAS;   NTSS-6;   Routine Blood Panel
5 Unknown  Study on the Role of Decompression of Lower Extremity Nerves for the Treatment of Patients With Symptomatic Diabetic Neuropathy With Chronic Nerve Compression
Condition: Painful Diabetic Neuropathy
Intervention: Procedure: Nerve Decompression
Outcome Measures: To determine if nerve decompression of lower extremities in patients suffering from painful symptomatic diabetic Neuropathy with chronic nerve compression, has a significant impact on alleviation of pain, and improvement in quality of life.;   To measure changes in quality of life. This includes medication changes, pain relief, restoration of sensation, etc.
6 Unknown  Treatment Study for Ischemic Optic Neuropathy With Opthalmic Timolol Maleate 0.5%
Conditions: Optic Neuropathy, Ischemic;   Anterior Ischemic Optic Neuropathy;   Ischemic Optic Neuropathy;   Optic Neuropathy, Anterior Ischemic
Intervention: Drug: Timolol maleate
Outcome Measures: Recruitment Rate of patients during the one year study to assess feasibility of a larger study;   Number of patients with adverse events;   Change in visual acuity at enrollment and three month follow up using a logMAR scale.;   Change in the mean deviation of actual versus predicted sensitivity of the visual field.;   Change in Colour vision as measured by HRR colour plates.;   Change in contrast sensitivity will be measured using the Pelli-Robson contrast sensitivity chart.
7 Recruiting The Effect of Mindfulness Based Stress Reduction in Patients With Painful Diabetic Peripheral Neuropathy
Conditions: Diabetes Mellitus;   Type I Diabetes;   Type II Diabetes;   Painful Diabetic Peripheral Neuropathy;   Chronic Pain
Intervention: Behavioral: Mindfulness Based Stress Reduction
Outcome Measures: Change from baseline in pain-related disability, as measured by the Brief Pain Inventory. Pain interference scale at 3-month post-intervention.;   Change from baseline in pain severity, as measured by the Brief Pain Inventory - Pain Severity scale, at 3 months post-intervention;   Change from baseline in mood states, as measured by the Profile of Mood States scale, at 3 months post-intervention.;   Overall change in status from baseline, as measured by Patient Global Impression of Change scale, at 3 months post-intervention.;   Change from baseline in stress, as measured by the Perceived Stress Scale, at 3 months post-intervention.;   Change from baseline in depressive symptoms, as measured by the Patient Health Questionnaire - 9 scale, at 3 months post-intervention;   Change from baseline in pain catastrophizing, as measured by the Pain Catastrophizing Scale, at 3 months post-intervention.;   Change from baseline in mindfulness, as measured by the Five Facet Mindfulness Questionnaire, at 3 months post-intervention.;   Change from baseline in quality of life, as measured by the Short-Form-12 Health Survey, at 3 months post-intervention.;   Change from baseline in quality of life, as measured by the Neuropathy-Specific Quality of Life Questionnaire (NeuroQOL).;   Change from baseline in quality of health and life, as measured by the The Summary of Diabetes Self-Care Activities (SDSCA).;   Change from baseline in adverse reactions as a result of their glycemic control, as measured by the Blood Sugar Reactions Questionnaire.;   Change from pre-intervention in biomarkers of stress, as measured by hair cortisol levels, at 3 months post-intervention.;   Change from baseline in glycemic control, as measured by blood levels of Hemoglobin A1c.
8 Recruiting The Nutritional Benefits of Metanx in Patients With Diabetic Peripheral Neuropathy (MEDIAN)
Conditions: Diabetic Peripheral Neuropathy;   B Vitamin Deficiency
Interventions: Other: Metanx;   Other: Placebo
Outcome Measures: Change in plasma methylmalonic acid (MMA) levels;   Change in plasma 5-methyltetrahydrofolate levels;   Change in plasma vitamin B6 levels;   Change in plasma vitamin B12 levels;   Change in urine microalbumin/creatinine ratio;   Change in epidermal nerve fiber density;   Change in neuropathic disability as measured by the Michigan Neuropathy Screening Instrument part B;   Change in neuropathic symptoms as measured by the Neuropathy Total Symptom Score-6questionnaire(NTSS-6);   Change in neuropathic symptoms as measured by the Neuropathy Total Symptom Score-6 questionnaire (NTSS-6)
9 Not yet recruiting Magnetic Resonance Diagnostics of Diabetic Peripheral Neuropathy
Conditions: Diabetes Mellitus, Type 1;   Diabetes Mellitus, Type 2;   Diabetic PolyNeuropathy;   Hereditary Axonal Neuropathy;   Hereditary Demyelinated Neuropathy;   PolyNeuropathy, Inflammatory Demyelinating, Chronic
Intervention:
Outcome Measures: Increase in magnetic resonance signal intensity of segmented nerves;   Determine diffusion weighted magnetic resonance values according to Neuropathy;   Examination of magnetic resoance morphological differences according to Neuropathy;   Correlation of magnetic resoance signal intensity value and nerve conduction thresholds
10 Recruiting Safety and Efficacy Study of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Diabetic Neuropathy
Conditions: Painful Diabetic Neuropathy;   Diabetic Neuropathy;   Neuropathy
Intervention: Drug: Clonidine Gel 0.1%
Outcome Measures: Change in average pain score over time.;   Mean daily average pain intensity Numeric Pain Rating Scale scores over time.;   Mean daily worst pain intensity Numeric Pain Rating Scale scores
11 Recruiting L-Serine Supplementation in Hereditary Sensory Neuropathy Type 1
Condition: Hereditary Sensory and Autonomic Neuropathy Type I
Interventions: Drug: L-serine;   Drug: placebo
Outcome Measures: Charcot Marie Tooth Neuropathy Score;   Measures of intraepidermal nerve fiber density (IENFD) on skin biopsy;   Measures of sensory and autonomic testing;   plasma measures of desoxysphingoid bases
12 Not yet recruiting Photobiomodulation Therapy Using the Realief Therapy System for the Treatment of Chemotherapy-associated Peripheral Neuropathy
Condition: Chemotherapy-induced Peripheral Neuropathy
Interventions: Device: photobiomodulation;   Other: Sham treatment;   Other: Physiotherapy
Outcome Measures: Improvement of total Neuropathy score;   Impact of 1 month treatment delay;   Time to improvement in initial Neuropathy score;   Time to maximum improvement in Neuropathy score;   Effect of treatment after discontinuation of therapy;   Response to combination of physiotherapy and photobiomodulation
13 Recruiting Characteristics of Popliteal Sciatic Nerve Block in Patients With and Without Diabetic Neuropathy
Condition: Diabetic Neuropathy
Intervention: Procedure: US-guided sciatic block at the popliteal crease (30 mL1:1 mixture of lidocaine 1% and bupivacaine 0.5%)
Outcome Measure: Duration of analgesia
14 Recruiting Improving Autonomic Function and Balance in Diabetic Neuropathy
Conditions: Diabetes;   Neuropathy;   Impaired Glucose Tolerance
Intervention: Behavioral: lifestyle modification
Outcome Measures: Autonomic Function: heart rate variability;   balance
15 Not yet recruiting Scrambler Therapy in the Treatment of Chronic Chemotherapy-Induced Peripheral Neuropathy
Condition: Neuropathy
Interventions: Device: Scrambler Therapy;   Device: Sham Therapy
Outcome Measures: Change in pain as measured by the Modified Brief Pain Index;   Changes in the complete Brief Pain Inventory score;   Changes in patient reported outcomes;   Changes in pain drug use
16 Recruiting Effect of EECP on Anterior Ischemic Optic Neuropathy
Condition: Anterior Ischemic Optic Neuropathy
Interventions: Device: Enhanced external counterpulsation;   Drug: Aspirin
Outcome Measures: visual acuity;   Ophthalmic artery blood flow velocity
17 Unknown  Small-fiber Neuropathy in Chronic Kidney Disease
Conditions: Small-Fiber Neuropathy;   Chronic Kidney Disease
Intervention: Other: Skin biopsy
Outcome Measures: The pathology of skin biopsy;   Intraepidermal fiber density;   Autonomic function;   Function of small-fiber sensory nerve
18 Unknown  Acupuncture for Peripheral Neuropathy
Condition: Peripheral Neuropathy Grade 2 or Greater
Intervention: Procedure: acupuncture
Outcome Measure: Improvement in peripheral Neuropathy
19 Recruiting Femoral Neuropathy After Anterior Cruciate Ligament Reconstruction: Femoral Nerve Block vs Patient-controlled Analgesia (PCA)
Condition: Femoral Neuropathy
Interventions: Procedure: Femoral nerve block;   Procedure: PCA morphine
Outcome Measure: Incidence of femoral Neuropathy
20 Unknown  Randomized Placebo-Controlled Trial of Glutamine for Breast Cancer Patients With Peripheral Neuropathy
Conditions: Peripheral Neuropathy;   Breast Cancer
Interventions: Drug: glutamine;   Drug: Placebo
Outcome Measure: effect of glutamine on peripheral Neuropathy